代谢相关脂肪性肝病非药物干预及中药治疗进展

Progress of Non-Drug Intervention and Traditional Chinese Medicine Treatment of Metabolic-Associated with Fatty Liver Disease

摘要: 代谢相关脂肪性肝病(Metabolic-associated with fatty liver disease, MAFLD)，目前已成为我国居民第一大肝脏疾病，也是全球最常见的慢性肝病。发病常与肥胖、糖尿病及生活不良习惯有关。目前MAFLD常缺乏有效的治疗药物。很幸运的是，大多数MAFLD如处于单纯性脂肪肝阶段不需要药物治疗，通过非药物干预治疗即可逆转单纯性脂肪肝，阻止脂肪肝进一步发展。目前，有关非药物干预治疗主要包括膳食干预、运动干预、针灸理疗、穴位埋线等方式。本文就MAFLD非药物干预及中药治疗进展综述如下。

Abstract: Metabolic-associated with fatty liver disease (MAFLD) has become the most common liver disease in China and the most common chronic liver disease in the world. The disease is often associated with obesity, diabetes and bad living habits. At present, there is a lack of effective drugs to treat MAFLD. Fortunately, most MAFLD patients in the stage of simple fatty liver disease do not require drug therapy. Non-drug intervention can reverse simple fatty liver disease and prevent further devel-opment of simple fatty liver disease. At present, the relevant non-drug intervention therapy mainly includes dietary intervention, exercise intervention, acupuncture therapy, acupuncture point cat-gut and so on. In this paper, the progress of non-drug intervention and traditional Chinese medicine treatment for MAFLD is summarized as follows.